Atlanta Capital Management’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$38.2M Buy
959,130
+172,163
+22% +$6.37M 0.17% 117
2022
Q2
$30.1M Sell
786,967
-31,485
-4% -$1.14M 0.13% 137
2022
Q1
$32.5M Buy
818,452
+5,171
+0.6% +$202K 0.12% 143
2021
Q4
$33.8M Buy
813,281
+204,658
+34% +$8.9M 0.11% 148
2021
Q3
$25.7M Buy
608,623
+119,587
+24% +$6.02M 0.09% 154
2021
Q2
$22.4M Buy
489,036
+173,984
+55% +$8.28M 0.08% 166
2021
Q1
$14.8M Buy
+315,052
New +$15.3M 0.05% 165

Other funds holding NRC

Atlanta Capital Management's NRC Position: Q3 2022 in Review

Atlanta Capital Management increased its NRC Health Common Stock (NRC) stake by 22% in Q3 2022, buying an estimated $6.37M and bringing the position to 959,130 shares worth $38.2M. The position accounts for 0.17% of the portfolio, ranked #117.

Atlanta Capital Management first reported a position in NRC in Q1 2021 and has held it in 7 quarters since. 110 funds tracked by Wall St. Rank hold NRC as of Q3 2022.

  • Atlanta Capital Management held 959,130 shares of NRC Health Common Stock worth $38.2M as of Q3 2022.
  • Atlanta Capital Management bought 172,163 NRC Health Common Stock shares in Q3 2022, an estimated $6.37M.
  • NRC Health Common Stock made up 0.17% of Atlanta Capital Management's portfolio in Q3 2022, its #117 holding.
  • Atlanta Capital Management first reported a position in NRC Health Common Stock in Q1 2021 and has held it in 7 quarters since.
  • 110 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2022.

Based on Atlanta Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.